Development of Calcification-Resistant Bovine Pericardium with PEO-SO3 (I): An implantation study of bovine pericardium at aorta and pulmonary artery in canine model / 대한흉부외과학회지

ABSTRACT

BACKGROUND: Calcific degeneration is unavoidable in either homo or heterografts implanted in the human body. We have developed a calcification-resistant cardiovascular tissue patch using a novel technique of anticalcification. MATERIALS AND METHODS: Fresh bovine pericardium was harvested at the slaughter house and transfered to the laboratory in Hank's solution. After trimming and fixing the pericardium, it was embedded in 4degree C 0.65% glutaraldehyde for a week and then washed by phosphate-buffered saline (PBS) of pH 7.4. This prepared pericardium was then stored in 2.5% sulphonated polyethyleneoxide (PEO-SO3) solution for 2 days at room temperature and reversed by 4degree C NaBH4 solution for 16 hours. To evaluate the calcification-resistance of surface modified bovine pericardium with PEO-SO3, either glutaraldehyde-treated (GA group, n=4) or PEO-SO3-treated pericardial patch (PEO-SO3 group, n=4) was implanted into adult mongrel dog to reconstruct the main pulmonary artery and the descending aorta using a partial clamp technique. After 1 month follow-up, the implanted patches were retrieved to evaluate the pathologic findings and the content of calcium and phosphorous. RESULTS: The PEO-SO3 group showed substantially less retraction and significantly less calcium deposition than the GA group in both aortic (7.10+/-1.05 vs. 13.81+/-2.33 mg/g of dried tissue) and pulmonary positions (1.55+/-0.29 vs. 6.72+/-0.70 mg/g) (p<0.01). Phosphorous contents were also less in the PEO-SO3 group than the GA group significantly, 8.11+/-1.07 mg/g vs. 19.33+/-4.31 mg/g in the aortic and 2.58+/-0.40 vs. 12.60+/-3.40 mg/g in thepulmonary position (p<0.01). CONCLUSIONS: These findings suggest that PEO-SO3 modified bovine pericardium is highly calcification-resistant but further study is needed to evaluate the long-term biological safety and compatibility of the prosthesis.